Yohei Okada

8.8k total citations · 3 hit papers
69 papers, 5.6k citations indexed

About

Yohei Okada is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Yohei Okada has authored 69 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 22 papers in Cellular and Molecular Neuroscience and 16 papers in Genetics. Recurrent topics in Yohei Okada's work include Pluripotent Stem Cells Research (27 papers), Neurogenesis and neuroplasticity mechanisms (15 papers) and CRISPR and Genetic Engineering (10 papers). Yohei Okada is often cited by papers focused on Pluripotent Stem Cells Research (27 papers), Neurogenesis and neuroplasticity mechanisms (15 papers) and CRISPR and Genetic Engineering (10 papers). Yohei Okada collaborates with scholars based in Japan, United States and Germany. Yohei Okada's co-authors include Hideyuki Okano, Shinya Yamanaka, Masaya Nakamura, Wado Akamatsu, Takuya Shimazaki, Gen Sobue, Satoshi Nori, Yoshiaki Toyama, Osahiko Tsuji and Kyoko Miura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yohei Okada

66 papers receiving 5.5k citations

Hit Papers

Variation in the safety of induced pluripotent stem cell ... 2009 2026 2014 2020 2009 2011 2011 200 400 600

Peers

Yohei Okada
Stuart M. Chambers United States
Su‐Chun Zhang United States
Alison C. Lloyd United Kingdom
Philip J. Horner United States
Su-Chun Zhang United States
Yohei Okada
Citations per year, relative to Yohei Okada Yohei Okada (= 1×) peers Asuka Morizane

Countries citing papers authored by Yohei Okada

Since Specialization
Citations

This map shows the geographic impact of Yohei Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohei Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohei Okada more than expected).

Fields of papers citing papers by Yohei Okada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohei Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohei Okada. The network helps show where Yohei Okada may publish in the future.

Co-authorship network of co-authors of Yohei Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Yohei Okada. A scholar is included among the top collaborators of Yohei Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohei Okada. Yohei Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sahashi, Kentaro, Yukiko Kamiya, Madoka Iida, et al.. (2025). An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment. Molecular Therapy — Nucleic Acids. 37(1). 102802–102802.
2.
Nakamura, Shinya, Y. Kamei, Aki Matsushima, et al.. (2025). Construction of contractile human iPSC-derived skeletal muscle tissues on 96-well scale microdevices. Journal of Bioscience and Bioengineering. 140(2). 98–106.
3.
Okada, Yohei, et al.. (2024). Evaluation of fatigue, load and the quality of chest compressions by bystanders in hot and humid environments. Resuscitation Plus. 20. 100818–100818. 1 indexed citations
4.
Sahashi, Kentaro, Kiyoshi Tachikawa, Michelle Nguyen, et al.. (2021). Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS. Molecular Therapy — Nucleic Acids. 24. 1–10. 27 indexed citations
5.
Iida, Madoka, Kentaro Sahashi, Naohide Kondo, et al.. (2019). Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy. Nature Communications. 10(1). 4262–4262. 15 indexed citations
6.
Nori, Satoshi, Yohei Okada, Soraya Nishimura, et al.. (2015). Long-Term Safety Issues of iPSC-Based Cell Therapy in a Spinal Cord Injury Model: Oncogenic Transformation with Epithelial-Mesenchymal Transition. Stem Cell Reports. 4(3). 360–373. 164 indexed citations
7.
Okada, Yohei, Shinsuke Shibata, Noriyuki Kishi, et al.. (2014). Involvement of ER Stress in Dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 Missense Mutations Shown by iPSC-Derived Oligodendrocytes. Stem Cell Reports. 2(5). 648–661. 97 indexed citations
8.
Kerever, Aurélien, F. Mercier, Risa Nonaka, et al.. (2014). Perlecan is required for FGF-2 signaling in the neural stem cell niche. Stem Cell Research. 12(2). 492–505. 67 indexed citations
9.
Higurashi, Norimichi, Taku Uchida, Christoph Lossin, et al.. (2013). A human Dravet syndrome model from patient induced pluripotent stem cells. Molecular Brain. 6(1). 19–19. 97 indexed citations
10.
Yagi, Takuya, Arifumi Kosakai, Daisuke Ito, et al.. (2012). Establishment of Induced Pluripotent Stem Cells from Centenarians for Neurodegenerative Disease Research. PLoS ONE. 7(7). e41572–e41572. 66 indexed citations
11.
Kobayashi, Yoshiomi, Yohei Okada, Go Itakura, et al.. (2012). Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity. PLoS ONE. 7(12). e52787–e52787. 227 indexed citations
12.
Muto, Jun, Takao Imai, Daisuke Ogawa, et al.. (2012). RNA-Binding Protein Musashi1 Modulates Glioma Cell Growth through the Post-Transcriptional Regulation of Notch and PI3 Kinase/Akt Signaling Pathways. PLoS ONE. 7(3). e33431–e33431. 74 indexed citations
13.
Shiozawa, Seiji, Kenji Kawai, Yohei Okada, et al.. (2010). Gene Targeting and Subsequent Site-Specific Transgenesis at the β- actin ( ACTB ) Locus in Common Marmoset Embryonic Stem Cells. Stem Cells and Development. 20(9). 1587–1599. 20 indexed citations
14.
Tomioka, Ikuo, Takuji Maeda, Hiroko Shimada, et al.. (2010). Generating induced pluripotent stem cells from common marmoset (Callithrix jacchus) fetal liver cells using defined factors, including Lin28. Genes to Cells. 15(9). 959–969. 101 indexed citations
15.
Kumagai, Gentaro, Yohei Okada, Junichi Yamane, et al.. (2009). Roles of ES Cell-Derived Gliogenic Neural Stem/Progenitor Cells in Functional Recovery after Spinal Cord Injury. PLoS ONE. 4(11). e7706–e7706. 97 indexed citations
16.
Ishii, Seiji, Yohei Okada, Toshihiko Kadoya, et al.. (2009). Stromal cell‐secreted factors promote the survival of embryonic stem cell‐derived early neural stem/progenitor cells via the activation of MAPK and PI3K‐Akt pathways. Journal of Neuroscience Research. 88(4). 722–734. 23 indexed citations
17.
Miura, Kyoko, Yohei Okada, Takashi Aoi, et al.. (2009). Variation in the safety of induced pluripotent stem cell lines. Nature Biotechnology. 27(8). 743–745. 664 indexed citations breakdown →
18.
Nagoshi, Narihito, Shinsuke Shibata, Yoshiaki Kubota, et al.. (2008). Ontogeny and Multipotency of Neural Crest-Derived Stem Cells in Mouse Bone Marrow, Dorsal Root Ganglia, and Whisker Pad. Cell stem cell. 2(4). 392–403. 291 indexed citations
19.
Okada, Yohei, Takuya Shimazaki, Gen Sobue, & Hideyuki Okano. (2004). Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells. Developmental Biology. 275(1). 124–142. 280 indexed citations
20.
Yokokura, Hisayuki, Yohei Okada, Osamu Terada, & H Hidaka. (1996). HMN-709, a Chlorobenzenesulfonamide Derivative, Is a New Membrane-Permeable Calmodulin Antagonist. The Japanese Journal of Pharmacology. 72(2). 127–135. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026